6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol

C77H99Cl3N16O5S — CID 157421233

About 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol

6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol (PubChem CID 157421233) has the molecular formula C77H99Cl3N16O5S and a molecular weight of 1467.17 g/mol. Its IUPAC name is 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol.

Molecular Properties

• Compound Name: 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol
• PubChem CID: 157421233
• Molecular Formula: C77H99Cl3N16O5S
• Molecular Weight: 1467.17 g/mol
• Exact Mass: 1464.68
• IUPAC Name: 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol
• SMILES: CC(=O)NCCN1CCN(c2cc(C)cc3[nH]ncc23)CC1(C)C.Cc1cc(N2CCN(CCNS(C)(=O)=O)C(C)(C)C2)c2cn[nH]c2c1.Clc1cc(N2CCc3cn[nH]c3C2)c2cc[nH]c2c1.O[C@@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ccc12.O[C@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ccc12
• InChI: InChI=1S/C18H27N5O.C17H27N5O2S.C14H13ClN4.2C14H16ClNO/c1-13-9-16-15(11-20-21-16)17(10-13)22-7-8-23(18(3,4)12-22)6-5-19-14(2)24;1-13-9-15-14(11-18-20-15)16(10-13)21-7-8-22(17(2,3)12-21)6-5-19-25(4,23)24;15-10-5-12-11(1-3-16-12)14(6-10)19-4-2-9-7-17-18-13(9)8-19;2*15-9-7-12(10-5-6-16-13(10)8-9)11-3-1-2-4-14(11)17/h9-11H,5-8,12H2,1-4H3,(H,19,24)(H,20,21);9-11,19H,5-8,12H2,1-4H3,(H,18,20);1,3,5-7,16H,2,4,8H2,(H,17,18);2*5-8,11,14,16-17H,1-4H2/t;;;11-,14+;11-,14-/m...11/s1
• InChIKey: BPKVVCATIOSYBI-XXHJFKJSSA-N
• XLogP: 14.02
• TPSA: 265.34 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 13
• Rotatable Bonds: 12
• Heavy Atoms: 102
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1467.17
LogP ≤ 5	14.02
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	13

Frequently Asked Questions

What is the IUPAC name of 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol?

The IUPAC name of 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol (CID 157421233) is 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol.

What is the SMILES notation for 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol?

The canonical SMILES for 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol is CC(=O)NCCN1CCN(c2cc(C)cc3[nH]ncc23)CC1(C)C.Cc1cc(N2CCN(CCNS(C)(=O)=O)C(C)(C)C2)c2cn[nH]c2c1.Clc1cc(N2CCc3cn[nH]c3C2)c2cc[nH]c2c1.O[C@@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ccc12.O[C@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ccc12.

What is the InChIKey of 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol?

The InChIKey is BPKVVCATIOSYBI-XXHJFKJSSA-N. The full InChI is InChI=1S/C18H27N5O.C17H27N5O2S.C14H13ClN4.2C14H16ClNO/c1-13-9-16-15(11-20-21-16)17(10-13)22-7-8-23(18(3,4)12-22)6-5-19-14(2)24;1-13-9-15-14(11-18-20-15)16(10-13)21-7-8-22(17(2,3)12-21)6-5-19-25(4,23)24;15-10-5-12-11(1-3-16-12)14(6-10)19-4-2-9-7-17-18-13(9)8-19;2*15-9-7-12(10-5-6-16-13(10)8-9)11-3-1-2-4-14(11)17/h9-11H,5-8,12H2,1-4H3,(H,19,24)(H,20,21);9-11,19H,5-8,12H2,1-4H3,(H,18,20);1,3,5-7,16H,2,4,8H2,(H,17,18);2*5-8,11,14,16-17H,1-4H2/t;;;11-,14+;11-,14-/m...11/s1.

What are the key properties of 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol?

6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol has a molecular weight of 1467.17 g/mol, XLogP of 14.02, 12 rotatable bonds, 10 hydrogen bond donors, and 13 hydrogen bond acceptors.

Where does this data come from?

All data for 6-(6-chloro-1H-indol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]acetamide;N-[2-[2,2-dimethyl-4-(6-methyl-1H-indazol-4-yl)piperazin-1-yl]ethyl]methanesulfonamide;trans-(1S,2R)-2-(6-chloro-1H-indol-4-yl)cyclohexan-1-ol is sourced from PubChem (CID 157421233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).